Вы искали: glijoma (Мальтийский - Английский)

glijoma
gliomaهمدرپ

glijoma malinna rekurrenti jew progressiva
recurrent or progressive malignant glioma

pazjenti bi glijoma malinna rikorrenti jew progressiva
patients with recurrent or progressive malignant glioma

pazjenti b’ glijoma malinna rikurrenti jew progressiva
patients with recurrent or progressive malignant glioma

monoterapija b’temodal fi glijoma rikurrenti jew progressiva
temodal monotherapy in recurrent or progressive glioma

temozolomide sun mogħti waħdu fi glijoma rikorrenti jew progressiva
temozolomide sun monotherapy in recurrent or progressive glioma

monoterapija b’temozolomide teva fi glijoma rikurrenti jew progressiva
temozolomide teva monotherapy in recurrent or progressive glioma

reazzjonijiet avversi f’pazjenti bi glijoma malinna rikorrenti jew progressiva
adverse reactions in patients with recurrent or progressive malignant glioma

cerepro ġie studjat f' 36 pazjent bi glijoma ta 'grad għoli.
cerepro has also been studied in 36 patients with high-grade glioma.

pazjenti adulti u pedjatriċi minn 3 snin ’ il fuq bi glijoma malinna rikorrenti jew progressiva
adult and paediatric patients 3 years of age or older with recurrent or progressive malignant glioma

tabella 5: reazzjonijiet avversi f’ pazjenti bi glijoma malinna rikurrenti jew progressiva
adverse reactions in patients with recurrent or progressive malignant glioma infections and infestations

pazjenti adulti u pedjatriċi minn 3 snin ‘ l fuq bi glijoma malinna rikurrenti jew progressiva:
3 adult and paediatric patients 3 years of age or older with recurrent or progressive malignant glioma:

- tfal li jkollhom minn tlett snin ‘ l fuq, adolexxenti, u pazjenti adulti bi glijoma malinna, bħal
- children from the age of three years, adolescents and adult patients with malignant glioma, such

gliolan jintuża f’pazjenti adulti bi glijoma (tip ta’ tumur tal-moħħ) malinna.
gliolan is used in adult patients with malignant glioma (a type of brain tumour).

f’pazjenti ta’ 3 snin jew akbar, tmz jintuża biss f’każ ta’ glijoma malinna rikurrenti jew progressiva.
in patients 3 years of age or older, tmz is only to be used in recurrent or progressive malignant glioma.

it-tliet studji ewlenin l-oħra involvew pazjenti bi glijoma malinna li reġgħet feġġet jew iggravat wara l- kura li kienu diġà ngħataw.
the other three main studies involved patients with malignant glioma that had come back or got worse after previous treatment.

it- tliet studji ewlenin l- oħra involvew pazjenti bi glijoma malinja li reġgħet feġġet jew li saret agħar wara l- kura li kienu diġà ħadu.
the other three main studies involved patients with malignant glioma that had come back or got worse after previous treatment.

tromboċitopenija u newtropenija ta’ grad 3 jew 4 seħħew f’19% u 17% rispettivament tal-pazjenti kkurati għal glijoma malinna.
grade 3 or 4 thrombocytopenia and neutropenia occurred in 19% and 17% respectively, of patients treated for malignant glioma.

gliolan huwa indikat f’pazjenti adulti għall-wiri ta’ tessut malinn waqt operazzjoni għal glijoma malinna (who grad iii u iv).
gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (who grade iii and iv).

il-kumitat iddeċieda li l-benefiċċji ta’ gliolan jisbqu r-riskji tiegħu għall-viżwalizzazzjoni ta’ tessut malinn waqt il-kirurġija ta’ glijoma malinna.
the committee decided that gliolan’s benefits are greater than its risks for the visualisation of malignant tissue during surgery for malignant glioma.